External GSSG enhances intracellular glutathione level in isolated cardiac myocytes
Descripción
Vol. 147, No. 2, 1987 September 15, 1987
EXTERNAL
BIOCHEMICAL
GSSG
AND BIOPHYSICAL
ENHANCES INTRACELLULAR
RESEARCH COMMUNICATIONS Pages 658-665
GLUTATHIONE
LEVEL
IN
ISOLATED CARDIAC MYOCYTES
C.Guarnieri,
Department
A.Fraticelli,
C.Ventura,
of Biochemistry,Centre
University
of Bologna,Via
I.Vaona,
of Research Irnerio
and
R.Budini
on Heart
48,40126
Metabolism,
Bologna,
Italy
Received July 30, 1987
The addition of external GSSG at concentrations in the range 50-500 uM produces in isolated adult rat heart myocytes an increase of GSH level and only a slight increase of GSSG level. external GSH at the above same indicated concenOn the contrary, The pretreattrations did not change the cell glutathione pool. ment of depleted the myocytes of the cells with diethylmaleate glutathione and enhanced the GSSG-induced replenishment effect on increase GSH level. On the contrary, the addition of GSH did not the concentration of cell glutathione. The level of cell GSH in diethylmaleate-treated myocytes was not increased after 30 min of incubation with cysteine, or acetylcysteine. The GSSG induced-stimulation on GSH level was not inhibian inhibitor of glutathione synted by buthionine sulfoximine, thesis. On the contrary, this stimulatory effect was inhibited by N, N-bis(2-chloroethyl)-N-nitrosourea, an inhibitor of glutathione reductase, or partially, by the remotion of glucose from the incubation medium. These results support the idea that the isolated adult rat heart myocytes are able to utilize external GSSG in order to increase glutathione pool, probably the intracellular through the reduction of the imported GSSG to GSH. 0 1987 Academic Press, SuikMARY:
IW.
Several
studies
functions status (2)
in (11,
or
diates
from (3).
functions
have demonstrated cells
Abbreviations:
protection
of
the
destructive
effects
it
a number
has long of
the cells
0 I987
of
of from
reactive
been recognized
important
cellular
plays
multiple
cellular toxic
substances
oxygen that
thiol
interme-
glutathione
processes,
detailed
BSO, buthionine sulfoximine; DEM, diethylmaleate; BCNU, N,N-bis (2-chloroethyll-N-nitrosourea.
0006-291X/87$1.50 Copyright All rights
glutathione
such as the maintenance
the
Although in
that
by Academic Press, Inc. in any form reserved.
of reproduction
658
Vol. 147, No. 2, 1987
information
about
te,
except
BY
using
for
the
liver
to
oxygen
reactive
glutathione
is in the
the heart
disulfide
these
disulfures
liver
(9).
Also
the
organ
which
been
described
present
study
myocytes
with
utilizes
highest
we
diethylmaleate
MATERIALS
the
examined
of
is
evidence reactive
it
the
trypeptide
mixed-
to this,
kidney
glutathione
glutathione
that
intracellular
could
(4);
external of
gluta-
is probable
glutathione
ability
oxygen
intracellular
muscIe
the
that
(7). of
trypeptide.The
appears sensitive
cardiac
removes
the
result
against
level
lung
external pool
and there
in the
circulating
to utilize
intracellular
the
last
particularly
and referring
of
that
is
stores
of external
reserve
This
from
is
trypep-
a lower
while
values,
adequately,
(8)
the
of
higher
be removed
utilization
intracellular
the
synthesis
could
that
contractility
sustain
inhibitor
tissues
protection
of muscle
“de nova”
glutathione
the
control
inadequa-
among the mamnalian
(4).
(5)
in
still
a specific
muscle
metabolites
involved
glutathione
have
muscle
is
ascertained
rate
the cardiac
does not
via
(BSO),
which
RESEARCH COMMUNICATIONS
or kidney.
has been
in heart
because
of
it
and kidney
interesting
the
sulfoximine
turnover
is evident
thione
such as liver
biosynthesis
with
If
of glutathione
tissues
has a different
and
synthesis
the
tide
(6)
AND BIOPHYSICAL
buthionine
glutathione
value
BIOCHEMICAL
the
than
is
following
the
the
the primary
CSH (10). isolated
in order
in
augment
recently
adult
level
it
has
In the cardiac
to replenish its
depletion
(DEM).
AND METHODS
Isolated adult cardiac myocytes were prepared accordingly Capogrossi et al.(ll). The hearts were excised from anaesthetized Sprague-Dawley rats (300 g) and in-mediately perfused via the aorcontaining (rrM): 116 NaCl, 5.4 ta at 37O C with a medium buffer KCl, 26 NaHCO3,l NaH2P04,l MgSO4 and 5.6 D-glucose which had been (buffer equilibrated with a 95% 02- 5% CO2 gas mixture (pH 7.4) Following this wash out, a recirculating perfusion was begun A). 659
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Vol. 147, No. 2, 1987
with 50 ml of buffer A with an additional 50 mg collagenase (Type I;Sigma) and CaC12 to give 50 uM. After 15-20 min the hearts were removed and the ventricles were chopped with scissors in buffer A containing collagenase. The resulting suspensions were filtered through nylon gauze and the cells were collected under gravity 6 min. buffer A after The cells were resuspended in 20 ml of containing 0.25 r-&i CaC12 and again sedimented under gravity. The myocy tes were then resuspended in medium A containing 10 nfvl Hepes, 1 n&I CaCl2 and 20 n-M D-glucose (buffer B). The pH 7.4, resulting cell suspensions were 70-80% in the rod form and were maintained upon incubation at 37O.C. After diluting the cell to protein concentration of 2 mg/ml, the cells were depleted of glutathione by incubating the myocytes at 37oC in the presence of 0.1 pi/ml diethylmaleate (DEM) dissolved in dimethylsulphoxide. buffer B After 10 min incubation, the cells were washed twice in and were then incubated with different concentrations of GSH or GSSG. After 30 or 60 min of incubation, the cells were collected by centrifugation at 50 g for 2 min and after washing twice with buffer B at 4’C, the myocytes were denaturated with cold 6% PCA. Following a sonification by a Labsonic sonifier cell disrupter (50 w; 10 set), the acid supernatant was separated by centrifugat ion, neutralized with 2 M K2q-0.3 M N-morpholinopropane sulforic acid and assayed inmediately for GSH + GSSG content. For GSSG measurement, the acid solution contained 50 n-M N-ethylmaleimide in order to trap GSH.The acid extracts were neutralized with 2 M K2C03-0.3 M N-morpholinopropane sulforic acid and assayed immediately for GSH + GSSG content according to the method of Tietze (12). The assay mixture for glutathione determination contained : 50 n-M potassium phosphate buffer, pH 7.4; 1 n-M EDTA; 0.1 n-&l 5’5-dithio bis (2-nitrobenzoic); 0.15 n&i NADPH; 6 units/ml glutathione reductase and an appropriate volume of neutralized sample. After 1 min, the increase in absorbance at 412 min was measured for 3 min using a double beam Perkin Elmer spectrometer mod.559. The proteins present in the perchloric-denaturated material were solubilized with 0.3 M KCH and determined according to Bradford (13) using bovine serum albumin as standard.
RESULTS Figure
1
shows
with
different
was
no
of
the
addition
an elevation
tracellular
cardiac (Figure
the
the
was
of
added
intracellular myocytes 2).
cardiac
On the
of GSH (25;
incubated 50;
100;
for
30 min
500 uM)
there
levels.
On
of GSSG at
above
50 pM,pro-
the
at
concentrations
GSH level.
slightly
of
concentration when above
GSH or GSSG did
incubated
contrary,
The
increased
concentrations
levels were
myocytes
GSH or GSSG intracellular
GSSG also
glutathione The
in
concentrations
change
contrary, duced
that
in
the
control
pretreatment
660
of
external
the
the
in-
oxid
ized
100 uM. not
change
conditions of
the
when I the for
cells
60 min for
IO
Vol.
147,
No.
2, 1987
BIOCHEMICAL
Figure
min
100
500
RESEARCH
COMMUNICATIONS
50
25
q
DEM than
whilst
BIOPHYSICAL
1. Effect of GSH or GSSC addition on intracellular GSHU or GSSC concentration in adult rat cardiomyocytes. After 30 of incubation,the cells were collected by centrifugation and after washing, the content of glutathione was determined as described in Methods.
with
lower
50
25
Control
AND
strongly
the
the
levels
reduced during
control
of
GSSG
were
the the
level following
not
modified
GSH 10
4
0.6
3
0.6
/ 1
/
GSH
which
60 min
of
by
drug.
the
remained incubation, When
the
GSSG
10 6
2
of
/
0.4
I ,‘e--w-
----A
02
&&i-i 0
0
0
Figure
30
60
i
0
in control 2. GSH and GSSG levels cardiomyocytes supplemented with Control; -ADEM-treated -omented cells; -w-GSSG supplemented Values are means + S.E. for four
661
I
J 30
and DEM-pretreated rat GSH or GSSG (5OpM). ccl Is;-+GSH supplecells. experiments.
60
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Vol. 147, No. 2, 1987 Table
I. Glutathione with compounds
levels in rat cardiomyocytes correlated with glutathione
Treatment
after treatment synthesis
GSH
GSSG (nmol/mg
Treated Treated Treated Treated Treated Treated Treated
(DEM) + GSSG (50pM) + GSSG + BSO (5nM) + GSSG + BCNU (IOOpM) + GSSG - glucose + Cysteine (In-M) + N-acetyl cysteine (Iti)
prot)
0.45
+ 0.02
0.09
+ 0.01
4.5 3.5 0.96
z 0.5 + 0.8 + 0.03
0.89 0.92
5 z
0.40 0.52 0.48 0.37 0.12 0.11
T 5 T T 2 &
1.44 : 0.05 0.04 0.03
0.03 0.04 0.05 0.03 0.02 0.03
BSO or BCNT were added 10 min before the incubation with GSSG. Values are means + S.E. for four experiments. The cardiomyocytes were incubated with GSSG, Cysteine or N-acetylcysteine for 30 min before glutathione determinations.
DEM-pretreated
myocytes
tracellular
concentration
incubation;
while
in
myocytes
cardiac
the
60 min
of
supplemented
of
GSH did
GSSG levels
enhanced
incubation.
with
not
At
DEM,
level
this
during
increased.
with the
50 uM GSH,
change
slowly
pretreated
50 ~J.M GSSG strongly after
were
of
in-
60 min
of
Differently,
the
incubation
cell
time,the
the
GSH
with
particularly
GSSG level
increased
too. Table
1 shows
effect
on
that cell
in
GSH level
reduced
when
the
slightly
when
glucose
Likewise
the
presence
GSH pool tion
of
stimulated the
did
intracellular
incubation
ccl 1s was
of
the
DEM-pretreated
myocytes
produced
the
by external
were
pre-treated
omitted
from
BSO did
with
not
modify
the
by GSSG incubation.
In
not
depleted
of
glutathione
restore
the
cell
concentration
of
DEM-treated
cells 662
GSSG
BCNU
incubation
of
increasing
50 uM
the
myocytes
acetyl-cysteine The
the
or
was more
mixture.
replenishment
addition, with
the
of incuba-
cysteine
or
by
the
alone
or
GSH level.
GSSG was with
increased 50 MM GSSG
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Vol. 147, No. 2, 1987 additional from
BSO.
the
The
presence
incubation
produced
mixture
while
GSSG level,
of
the
a lesser
also
presence
evident
BW
or
the
caused of
remotion
an increase
cysteine
enhancing
of
glucose
of
the
cell
or N-acetylcysteine
effect.
DISCUSSION The
present
myocytes
study
to
indicates
external
particularly
when
depleted
by DElvI preincubation.
synthesis
inhibitor
(41, it
mediated utilization
This
of
conclusion
obtained
by
myocytes.
in
adding
part
external
by
the
enyme
glutathione
of
the
cells
with
tathione
reductase
was
mited
recovery
suggests
a probably
glucose lated dent
in GSH
deprivation. ef :fect to
the
on the energetic
GSSG, derives
from
the
not
further
replenishement
undergo
the
the 663
is
1 ikely
reduction
enzyme
effect this
experiments
medium.
In
glutathione
myocytes.
GSH
hypothein
fact,
which the
li-
cells
NADPH that
glu-
on
glutathione-depleted of
the
pretreatment
the
confirm
is of
the of
to
possibility,
replenishment
that
increasing
seems
the
of
and
inhibitor the
ef feet
GSH-depleted
it
production
of
to
fact
from
in
inadequate
level
is
same negative
synthesis,
incubation
level
Another
and
myocytes
reduces
(14),
removed
nova”
an effective
evidence
glutathione
the
reductase.The
Additional
this
with
an effect
acetylcysteine
cardiac
sis. glucose
or
by “de
by external
is
glutathione
such
by the
pool
stimulated
level,
glutathione
interfere
that
confirmed
level
GSH
precursors.
GSSG favour
BGNU,
the
of
cardiac
adult
a known
to
likely
that
GSSG enter
of
BSO,
external
cysteine
Excluding
of
pool
able
very of
myocytes-glutathione that
not
aminoacids
is
cellular Since
appears
the
exposure
an increase
the
is
breakdown
by
the
GSSG produces
evident
replenishement,
that
secondary
the pool
to
GSSG-stimuis
depen-
Vol. 147, No. 2, 1987
The
fact
BIOCHEMICAL
that
glutathione
external
pool
damaged
AND BIOPHYSICAL
GSH does
suggests
that
and show a rather
not
the
RESEARCH COMMUNICATIONS
increase
sarcolenmal
specific
property
intracellular
the
membranes are of being
not
impermeable
to GSH. The ability also
of
evident
external
in control
effect
of GSH level
during
the
(data
not
cells,
shown).
cells,
is
following
in which
level
GSSG to elevate
This
up to 60 min of
The remotion
the
addition
latter
to glutathione
value
GSH level
is
DEM. The maximum while
incubation,
to
decrease
to
the
of GSSG enhances
slowly
DEM-treated
linearly
the GSH
perfusion. external
being
GSSG by cardiomyocytes
condition,such
cells a process
supports could
idea
the
be alternative
synthesis.
the concentration
of external
level
is close
present
to
to suggest unless
tends
is opposite
Since
scle,
with
30 min of
in glutathione-depleted
in this
tempted
treated
after
behaviour
mechanism of
more accentuated that
reached
30 min,
the
not
the myocytes
those this
GSSG could
GSSG able
to
increase
in the circulation
mechanism also pass through
(151,
operates the
the GSH
in the
vascular
we
are
heart
mu-
wall.
ACKNOWLEDGEMENTS The authors thank Mrs. A. Zarri help. This research received financial blica Istruzione (Roma).
for
her
support
invaluable from
secretarial
the Minister0
Pub-
REFERENCES 1. Larsson,
A., Orrenius, S., Holmgren, A. and Mannerwik, B. (1983) Functions of Glutathione, Raven Press,New York. 2. Gilbert, H.F. (1984) in Methods in Enzymology (Weld, F. and Moldave, K., eds.), vol. 107, pp. 330-351, Academic Press, New York. 3. Meister, A. (1983) Science 220, 472-477. 4. Griffith, O.W. and Meister, A. (1979) Proc. Natl. Acad. Sci. U.S.A. 76, 5606-5610. teds.)
664
Vol. 147, No. 2, 1987
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
5. Guarnieri, C., Flamigni, F. and Caldarera, C.M. (1980) 3. Mol. Cell. Cardiol. 12, 797-808. 6. Doroshow, J.H., Locker, C.Y. and Myers, C.E. (1981) J. Clin. Invest. 65, 128-134. 7. Talesmik, J. and Tsoporis, J. (1984) J. Mall. Cell. Cardiol. 16, 573-576. 8. Guarnieri, C., Vaona, I., Scheda, M. and Caldarera, C.M. (1986) Free Rad. Res. Comns. 2, 101-105. 9. Harrisch, G. and Mahmoud, M.F. (1980) Hoppe-Seyler’s 2. Physiol. Chem. 361, 1859-1862. 10. Berggren, M., Dawson, J. and Moldeus, P. (1984) FEBS Lett. 176, 189-192. Il. Capogrossi, M., Kort, A.A., Spurgeon, H.A. and Lakatta, E.G. (1986) J. Gen. Physiol. 88, 589-613. 12. Tietze, F. (1969) Anal. Biochem. 27, 502-522. 13. Bradford, M.M. (1976) Anal. Biochem. 72, 246-254. 14. Babson, J.R., Abell, N.S. and Reed, D.J. (1981) Biochem. Pharmacol. 30, 2299-2304. 15. Griffith, O.W. and Meister, A. (1979) Proc. Natl. Acad. Sci. U.S.A. 76, 5606-5610.
665
Lihat lebih banyak...
Comentarios